RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families

scientific article published on 20 December 2013

RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1047995151
P356DOI10.1186/BCR3589
P932PMC publication ID3978715
P698PubMed publication ID24359560
P5875ResearchGate publication ID259446630

P50authorRita SchmutzlerQ21264574
Alfons MeindlQ63015490
Barbara WappenschmidtQ63444312
Kerstin RhiemQ92889178
P2093author name stringEric Hahnen
Heide Hellebrand
Jan Hauke
Lutz Garbes
Alexandra Becker
Stefanie Engert
Gioia Schnurbein
Guido Neidhardt
Nana Weber-Lassalle
P2860cites workGermline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility geneQ28280022
Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico predictionQ31109088
Genetic susceptibility to triple-negative breast cancerQ36846498
Germline RAD51C mutations confer susceptibility to ovarian cancerQ57266552
RAD51C is a susceptibility gene for ovarian cancerQ57306209
Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patientsQ85077261
P433issue6
P921main subjectovarian cancerQ172341
P304page(s)R120
P577publication date2013-12-20
P1433published inBreast Cancer ResearchQ2208481
P1476titleRAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families
P478volume15

Reverse relations

cites work (P2860)
Q40495288A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer
Q48097657Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers
Q93164325Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer
Q51764547Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.
Q28253197Genetic testing for RAD51C mutations: in the clinic and community
Q28271817Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer
Q53230114Loss of Rad51c accelerates tumourigenesis in sebaceous glands of Trp53-mutant mice.
Q35657899Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic
Q47141035Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations
Q59538863Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers
Q57083786RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families
Q39434998Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH.
Q33769821Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Search more.